Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2018841000168118 | Maxalt (rizatriptan 5 mg) wafer, 2 wafers (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2018851000168116 | Maxalt 5 mg wafer, 2 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Maxalt 5 mg wafer, 2 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Maxalt 5 mg wafer, 2 | Is a | rizatriptan 5 mg wafer, 2 | true | Inferred relationship | Some | ||
| Maxalt 5 mg wafer, 2 | has TPUU | Maxalt 5 mg wafer | true | Inferred relationship | Some | 1 | |
| Maxalt 5 mg wafer, 2 | has TP | Maxalt | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Maxalt 5 mg wafer, 2, blister pack | Is a | True | Maxalt 5 mg wafer, 2 | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Trade product pack reference set
FHIR